Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Raised to $120 at Oppenheimer

July 30, 2021 6:27 AM
Oppenheimer analyst Suraj Kalia raised the price target on Edwards Lifesciences (NYSE: EW) to $120.00 (from $97.00) while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles